COLL Company Profile and Key Details

Q: Who are the executives of COLL?

Mr. Bart J. DunnExecutive Vice President of Strategy & Corporation Devel.Mr. Scott SudduthHead of Technical OperationsMs. Marlo ManningHead of HRMs. Shirley R. KuhlmannExecutive Vice President, Gen. Counsel, Chief Admin. Officer & Sec.Ms. Alex DasallaHead of Investor RelationsDr. Richard Malamut M.D.Executive Vice President & Chief Medical OfficerDr. Thomas B. Smith FAAFP, M.D.Executive Vice President & Chief Medical OfficerMr. Joseph J. CiaffoniPres, Chief Executive Officer & DirectorMs. Colleen TupperExecutive Vice President & Chief Financial OfficerMr. Scott DreyerExecutive Vice President & Chief Commercial OfficerMr. Michael Thomas Heffernan B.S. Pharm, R.Ph.Co-Founder & Chairman

NASDAQ : COLL

Collegium Pharmaceutical

$28.74

-0.375-1.29%

Open: 11:47 AM

51.46

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Collegium Pharmaceutical, Inc. (COLL) stock declined over -1.29%, trading at $28.74 on NASDAQ, down from the previous close of $29.11. The stock opened at $29.01, fluctuating between $28.02 and $29.79 in the recent session.

Stock Snapshot

29.11

Prev. Close

931.98M

Market Cap

28.02

Day Low

3.61

P/E Ratio

7.97

EPS (TTM)

8.49

Cash Flow per Share

29.01

Open

32.43M

Number of Shares

29.79

Day High

95.68%

Free Float in %

6.05

Book Value

301.81K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 06, 2026	31.68	33.03	28.90	29.11	2.13M
Aug 05, 2026	35.71	36.42	35.42	35.74	402.42K
Aug 04, 2026	35.46	36.00	35.00	35.73	438.6K
Aug 03, 2026	35.43	36.45	34.68	35.58	374.45K
Jul 31, 2026	35.71	36.28	34.40	35.39	288.49K
Jul 30, 2026	35.72	36.40	35.17	35.98	251.18K
Jul 29, 2026	35.96	36.64	35.96	36.29	348.29K
Jul 28, 2026	36.00	36.56	35.52	35.90	224.6K
Jul 27, 2026	35.44	36.03	35.26	35.52	309.71K
Jul 24, 2026	35.72	35.85	35.16	35.20	254.18K
Jul 23, 2026	34.32	35.69	34.00	35.59	253.22K
Jul 22, 2026	35.89	36.51	34.59	34.72	231.34K
Jul 21, 2026	35.26	36.30	35.15	35.85	301.58K
Jul 20, 2026	36.15	36.92	35.31	35.54	383.55K
Jul 17, 2026	36.00	36.93	35.50	36.08	316.58K
Jul 16, 2026	37.00	37.70	36.23	36.27	379.95K
Jul 15, 2026	34.89	36.76	34.51	36.72	623.86K
Jul 14, 2026	34.57	35.28	34.25	35.02	552.75K
Jul 13, 2026	35.15	35.53	34.65	34.82	343.22K
Jul 10, 2026	36.12	36.27	35.14	35.23	286.22K

Contact Details

Stoughton, MA 02072

United States

https://www.collegiumpharma.com 781 713 3699

About Company

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular drug is prescribed for patients experiencing severe, persistent pain that necessitates daily, continuous, long-term opioid therapy. The company's portfolio also encompasses Nucynta ER and Nucynta IR, which are extended-release and immediate-release versions of tapentadol, respectively. Founded in 2002, the enterprise initially operated under the name Collegium Pharmaceuticals, Inc., before officially adopting its current identity as Collegium Pharmaceutical, Inc. in October 2003. The company's corporate headquarters are situated in Stoughton, Massachusetts.

Stock Peers

ITCI

Intra-Cellular Therapies, Inc.$131.87 LNTH

-0.43-0.42%

Lantheus Holdings, Inc.$101.07 ANIP

2.75+3.44%

ANI Pharmaceuticals, Inc.$82.63 SUPN

-0.15-0.32%

Supernus Pharmaceuticals, Inc.$46.76 ETON

0.21+0.46%

Eton Pharmaceuticals, Inc.$46.18 HROW

0.51+1.29%

Harrow Health, Inc.$39.92 INDV

-0.06-0.15%

Indivior Pharmaceuticals Inc$38.67 PAHC

-0.51-1.42%

Phibro Animal Health Corporation$35.50 PETQ

-0.01-0.03%

PetIQ, Inc.$30.98 DCPH

0.02+0.08%

Deciphera Pharmaceuticals, Inc.$25.59

Frequently Asked Questions

What is the current Collegium Pharmaceutical, Inc. (COLL) stock price?

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stock price is $28.74 in the last trading session. During the trading session, COLL stock reached the peak price of $29.79 while $28.02 was the lowest point it dropped to. The percentage change in COLL stock occurred in the recent session was -1.29% while the dollar amount for the price change in COLL stock was - $0.38.

COLL's industry and sector of operation?

The NASDAQ listed COLL is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Collegium Pharmaceutical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of COLL?

Mr. Bart J. Dunn
Executive Vice President of Strategy & Corporation Devel.
Mr. Scott Sudduth
Head of Technical Operations
Ms. Marlo Manning
Head of HR
Ms. Shirley R. Kuhlmann
Executive Vice President, Gen. Counsel, Chief Admin. Officer & Sec.
Ms. Alex Dasalla
Head of Investor Relations
Dr. Richard Malamut M.D.
Executive Vice President & Chief Medical Officer
Dr. Thomas B. Smith FAAFP, M.D.
Executive Vice President & Chief Medical Officer
Mr. Joseph J. Ciaffoni
Pres, Chief Executive Officer & Director
Ms. Colleen Tupper
Executive Vice President & Chief Financial Officer
Mr. Scott Dreyer
Executive Vice President & Chief Commercial Officer
Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.
Co-Founder & Chairman

How COLL did perform over past 52-week?

COLL's closing price is 0.62% higher than its 52-week low of $28.02 where as its distance from 52-week high of $50.79 is -42.68%.

How many employees does COLL have?

Number of COLL employees currently stands at 423.

Link for COLL official website?

Official Website of COLL is: https://www.collegiumpharma.com

How do I contact COLL?

COLL could be contacted at phone 781 713 3699 and can also be accessed through its website. COLL operates from 100 Technology Center Drive, Stoughton, MA 02072, United States.

How many shares of COLL are traded daily?

COLL stock volume for the day was 301.81K shares. The average number of COLL shares traded daily for last 3 months was 408.62K.

What is the market cap of COLL currently?

The market value of COLL currently stands at $931.98M with its latest stock price at $28.74 and 32.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	423
Beta	0.73
Sales or Revenue	$566.77M
5Y Sales Change%	0.97%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Employees	423
Beta	0.73
Sales or Revenue	$566.77M
5Y Sales Change%	0.97%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

COLL Company Profile and Key Details

Collegium Pharmaceutical

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Dividend & Fair Value

Valuation Metrics

Company Overview

Price Forecast & Outlook

Key Takeaways